Alzheimer’s disease

Halting the disease progression would lead to great benefits to patients, families and caregivers.

Read more

Parkinson’s disease

The medical need of treatments is high due to the lack of drugs affecting the underlying pathology.

Read more

Complete Spinal Cord Injury

We are developing an innovative treatment that aims to improve the patients’ quality of life.

Read more

Press releases

• February 14, 2019 - Regulatory press releaseFull Year Report January – December 2018
• February 13, 2019 - Regulatory press releaseBioArctic’s product candidate SC0806 for treatment of patients with complete spinal cord injury is now in Phase 2
• February 11, 2019 - Regulatory press releaseBioArctic: U.S. Food and Drug Administration Approves Investigational New Drug Application for ABBV-0805

Archive

Full Year Report 2018

BioArctic AB published the Full Year Report for the period January – December 2018 on February 14, 2019.

• Report
• Presentation
• Webcast

Read the report

Calendar

• March 6, 2019Carnegie Nordic Healthcare Seminar in Stockholm, Sweden
• April 15, 2019 - April 18, 2019Annual Report 2018
• May 9, 2019Interim Report January – March 2019

All events